Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-12-23

FDA Approved: RANOLAZINE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved Aurobindo Pharma Limited's generic Ranolazine under an Original Application (ANDA209081).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ranolazine (ranolazine)

Snippet

ORIG AP for RANOLAZINE (RANOLAZINE)